Keyword: Siegfried

Strategy & Management

Innovative Chemistry Between Mountains and Lakes

09.12.2019 -

Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan...

Strategy & Management

Experts Statements: Marianne Späne, Siegfried

05.09.2019 - The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...

Chemistry & Life Sciences

Trend Barometer of Specialty Chemicals Industry

16.07.2019 - The 34th and, so far, biggest edition of Chemspec Europe attracted a total of 4,295 trade visitors from 53 countries to the exhibition grounds of Messe Basel, Switzerland. During...

Markets & Companies

Opportunities for Western CDMOs in China

29.11.2018 - As part of its journey toward being a full-fledged advanced economy, the role and presence of China within the pharmaceutical industry has rapidly evolved throughout the recent...

Plant Construction & Process Technology

M&A in Pharma and CRO/CMO Industry

19.09.2018 - Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself...

Plant Construction & Process Technology

A Wide Spectrum of Contract Services

19.09.2018 - With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...

News

Wolfgang Wienand to Succeed Rudolf Hanko as CEO of Siegfried

04.06.2018 - Wolfgang Wienand has been appointed as new CEO of Siegfried with effect from Jan. 1, 2019. Rudolf Hanko, the group’s current CEO, will step down on Dec. 31, 2018. The board has...

Research & Innovation

Experts Statements: Dr. René Imwinkelried, Siegfried

12.12.2016 - Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...